Label
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a front view of the label of our new design;
FIG. 2 is side view of of the label depicted in FIG. 1.
FIG. 3 is a rear view of the label of FIG. 1;
FIG. 4 is a end view of the label of FIG. 1; and,
FIG. 5 is an opposite end view of the nozzle of FIG. 1.
Claims
The ornamental design for a label, as shown and described.
Referenced Cited
U.S. Patent Documents
1999011 | April 1935 | Wasser |
D161797 | January 1951 | Smith |
D163774 | June 1951 | Schwartz |
D194090 | November 1962 | Mercourelli |
D305439 | January 9, 1990 | Spendier |
D398391 | September 15, 1998 | Kutchko |
D401259 | November 17, 1998 | Chapman et al. |
D416050 | November 2, 1999 | Caloia et al. |
D425536 | May 23, 2000 | Schelling et al. |
D428932 | August 1, 2000 | Caloia et al. |
D453796 | February 19, 2002 | Lewicki, Sr. |
D470186 | February 11, 2003 | Fuss |
D490932 | June 1, 2004 | Mammone |
D509024 | August 30, 2005 | Pimentel |
Patent History
Patent number: D516627
Type: Grant
Filed: Jan 19, 2005
Date of Patent: Mar 7, 2006
Assignee: Glaxo Group Limited (Greenford)
Inventors: Matthew Spencer Collins (Bedfordshire), Michael Birsha Davies (Ware), James William Godfrey (Ware)
Primary Examiner: Robert M. Spear
Attorney: James P. Riek
Application Number: 29/221,553
Type: Grant
Filed: Jan 19, 2005
Date of Patent: Mar 7, 2006
Assignee: Glaxo Group Limited (Greenford)
Inventors: Matthew Spencer Collins (Bedfordshire), Michael Birsha Davies (Ware), James William Godfrey (Ware)
Primary Examiner: Robert M. Spear
Attorney: James P. Riek
Application Number: 29/221,553
Classifications
Current U.S. Class:
Label Or Tag (6) (D20/22)